Попробовать демо Открыть счет
Торговля
CFD
Бинарные опционы
Крипто
Банкинг
B2B
Рынки
О нас
Попробовать демо Открыть счет

Catalent to acquire Juniper Pharmaceuticals for $11.50/share

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Tuesday, the US drug contract producer stated it would acquire Juniper Pharmaceuticals for $11.50 a share in cash, valuing the company at around $127.7M.
Back to articles

Actual Topics

03 Jul 2018

KazMunayGaz's deal with China's CEFC falls apart

According to Reuters, the state energy company KazMunayGaz's deal to sell its 51% majority stake in Romania's arm to China's energy titam CEFC has collapsed.

03 Jul 2018

Austria prepares to protect its borders

The Austrian government has announced that the country is ready to protect its southern border, if a migration deal is made within Germany.

03 Jul 2018

European shares jump on Tuesday

European stock markets surged on Tuesday morning, as the news that the German government has made up its mind in regards to migration policy pushed the stocks higher.